News
About the company
Domestic manufacturer of medicines that meets all modern standards of quality and management. The company is certified according to GMP PIC / S and ISO19001 standards.
In 2018, the Reb-Pharma assortment portfolio includes more than 50 types of medicines, including those that have no analogues in the Republic of Belarus.
So, in 2017, the company produced direct-acting antiviral drugs - GEPASOFT (sofosbuvir), DACLASOFT (daclatasvir).
One of the priority areas is the release of drugs for the treatment of glaucoma: LATADOR, R-DORZA, R-DORZAKT, FAVULENZ.
ERKETON - the only non-steroidal anti-inflammatory drug in the Republic of Belarus containing ketorolac in the form of eye drops.
REBLAX - a central muscle relaxant with analgesic and anti-inflammatory effects, the active substance is a semi-synthetic alkaloid thiocolchicoside.
The Reb-Pharma company strives to achieve a priority strategic goal - to provide consumers with high-quality and effective medicines at affordable prices.
